News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Vows to Keep Up Drug Hunt; to Strengthen Pipeline With 72 New Molecular Entities



9/5/2012 6:54:40 AM

Roche Holding AG (ROG.VX) Wednesday pledged to continue spending more than 8 billion Swiss francs ($8.4 billion) a year to find and develop new drugs, defying a wider trend in the pharmaceutical industry to cut costs as many of the Swiss drug maker's rivals are faced with competition from cheap generics for their best-selling products.

Roche has a stable of relatively new cancer drugs that still see enviable sales growth, and few of its blockbuster products face imminent competition.

Read at RTT News
Read at Reuters
Read at Fox News
Read at Wall Street Journal
Read at Nasdaq


comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES